-
SCIENCE BLOG | How much do you know about leukemia?
Leukemia, also known as blood cancer, is a kind of clonal malignant disease with abnormal hematopoietic stem cells (HSC). The pre-leukemic HSC clones lose the ability to further differentiate and mature, thus stagnate at different stag...Read more -
Visit us at 2023 AACC Clinical Lab Expo
We will be having a booth at 2023 AACC Clinical Lab Expo. Expo Dates: July 25-27, 2023 Venue: Anaheim Convention Center, Anaheim, California, United States Booth No.: 3071 (Hall B) Come to visit us. We look forward to seeing you!Read more -
International HPV Awareness Day, A Concerted Effort to End HPV
March 4, 2023 is the sixth “HPV Awareness Day”, which was initiated by the International Papillomavirus Society (IPVS) to raise awareness of HPV prevention and control, call for public attention and understanding of the human papillomavirus (HPV) and its dangers, and eli...Read more -
[GOOD NEWS] ZEESAN’s MDR-TB Test Kit (MMCA) was listed for priority approval of medical devices in NMPA
On March 20, the Center for Medical Device Evaluation, National Medical Products Administration (NMPA, China) publicized the list of IVD products that are obtained the priority approval of medical devices. MDR-TB Test Kit(Cat. No.: 801213) from Zeesan Biotech was passed ...Read more -
ZEESAN showcases its total solution to molecular diagnositics at Medlab Middle East 2023
ZEESAN brought its total solution to molecular diagnostics and its fully automated system to participate in the Medlab Middle East 2023 in Dubai, UAE, from February 6-9, 2023. Medlab Middle East is the largest laboratory equipment exhi...Read more -
Scaling up diagnosis to end TB epidemic – ” Global Plan to End TB, 2023-2030″, ZEESAN in action
The Stop TB Partnership, an organization managed by the United Nations Office for Project Services (UNOPS), released the “Global Plan to End TB, 2023-2030″ (hereinafter “Global Plan”) on August 16, 2022. The Global Plan to end TB, a major public health challenge, by 2030...Read more
Newsroom
Interested to Know More about Our Solution to Molecular Diagnostics?